Bristol-Myers Squibb - About Us - Corporate Governance

Welcome Message

Our Company

Awards & Recognition

Corporate Governance

	Management Council
	Board of Directors
	Reports of Insider Transactions
	Committee Charters
	Corporate Governance Guidelines
	Additional Policies and Guidelines
	Codes of Conduct
	Articles of Incorporation (PDF)
	Bylaws (PDF)

Corporate Compliance

Our Websites

Business Links

» BMS.com Home » About Us » Corporate Governance » Management Council

Management Council

James M. Cornelius
Chairman and CEO

Lamberto Andreotti
Executive Vice President and Chief Operating Officer, Bristol-Myers Squibb

John E. Celentano
Senior Vice President, Strategy and Productivity Transformation

Brian Daniels, M.D.
Senior Vice President, Global Development, R&D

Anthony C. Hooper
President, U.S. Pharmaceuticals

Jean-Marc Huet
Senior Vice President and Chief Financial Officer

Sandra Leung
Senior Vice President, General Counsel and Corporate Secretary

Anthony McBride, Ph.D.
Senior Vice President, Human Resources

Elliott Sigal, M.D., Ph.D.
Executive Vice President, Chief Scientific Officer and President, R&D

Robert T. Zito
Senior Vice President, Corporate and Business Communications, and Chief Communications Officer

[Top Page] [Search] [Index] [Contact] [Home]

Italicized product names are trademarks of Bristol-Myers Squibb Company or one of its divisions or subsidiaries. Abilify is a trademark of Otsuka Pharmaceutical Co., Ltd. Erbitux is a trademark of ImClone Systems Incorporated. EMSAM is a trademark of Somerset Pharmaceuticals, Inc. Glucophage, Glucovance and Metaglip are trademarks of Merck Santé S.A.S., an associate of Merck KGaA of Darmstadt, Germany. Avapro, Avalide and Plavix are trademarks of sanofi-aventis. Sinemet CR is a trademark of Merck & Co., Inc.